Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study
{{output}}
Background: Migraine is one of the leading causes of disability worldwide. Erenumab is a fully human monoclonal antibody that targets the calcitonin gene-related peptide (CGRP) receptor. This study aimed to evaluate real-world ev... ...
